Payment overview · 2025
General Payments
$90.83
1 reported records · 1 companies
Healthcare provider profile · identity verified
Dmitry Tarasevich, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · PETERBOROUGH, NH · NPI 1215119532
Verified facts
What the public records show
CMS Open Payments records show Dmitry Tarasevich, M.D. received $90.83 in general payments during 2025 across 1 reported records.
EMD Serono, Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| EMD Serono, Inc. | Unresolved — no canonical attribution shown | $90.83 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $90.83 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 767 | 212 |
| Amlodipine Besylate | Amlodipine Besylate | 504 | 135 |
| Warfarin Sodium | Warfarin Sodium | 445 | 103 |
| Lisinopril | Lisinopril | 413 | 115 |
| Losartan Potassium | Losartan Potassium | 277 | 76 |
| Metoprolol Succinate | Metoprolol Succinate | 233 | 60 |
| Metformin Hcl | Metformin Hcl | 225 | 65 |
| Levothyroxine Sodium | Levothyroxine Sodium | 224 | 58 |
| Tamsulosin Hcl | Tamsulosin Hcl | 224 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 199 | 56 |
| Sertraline Hcl | Sertraline Hcl | 179 | 44 |
| Allopurinol | Allopurinol | 176 | 53 |
| Omeprazole | Omeprazole | 173 | 42 |
| Eliquis | Apixaban | 165 | 31 |
| Simvastatin | Simvastatin | 165 | 44 |
| Pantoprazole Sodium | Pantoprazole Sodium | 163 | 43 |
| Lorazepam | Lorazepam | 156 | 52 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 145 | 47 |
| Potassium Chloride | Potassium Chloride | 142 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 140 | 36 |
| Furosemide | Furosemide | 131 | 41 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 125 | 40 |
| Trazodone Hcl | Trazodone Hcl | 87 | 18 |
| Montelukast Sodium | Montelukast Sodium | 80 | 18 |
| Atenolol | Atenolol | 75 | 18 |
| Finasteride | Finasteride | 75 | 18 |
| Gabapentin | Gabapentin | 70 | 27 |
| Alendronate Sodium | Alendronate Sodium | 68 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 65 | 21 |
| Metformin Hcl Er | Metformin Hcl | 57 | 15 |
| Clonazepam | Clonazepam | 55 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 54 | 14 |
| Xarelto | Rivaroxaban | 54 | 13 |
| Cephalexin | Cephalexin | 53 | 24 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 51 | 13 |
| Pravastatin Sodium | Pravastatin Sodium | 50 | 13 |
| Sildenafil Citrate | Sildenafil Citrate | 48 | suppressed |
| Glipizide | Glipizide | 45 | suppressed |
| Azithromycin | Azithromycin | 44 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 43 | 14 |
| Escitalopram Oxalate | Escitalopram Oxalate | 42 | 11 |
| Ozempic | Semaglutide | 42 | suppressed |
| Jantoven | Warfarin Sodium | 41 | 12 |
| Divalproex Sodium | Divalproex Sodium | 40 | suppressed |
| Bupropion Xl | Bupropion Hcl | 39 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 38 | 11 |
| Alprazolam | Alprazolam | 36 | suppressed |
| Prednisone | Prednisone | 36 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 34 | suppressed |
| Pregabalin | Pregabalin | 33 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 30 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 30 | 15 |
| Lovastatin | Lovastatin | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 20 |
| Carvedilol | Carvedilol | 27 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 21 |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Levetiracetam | Levetiracetam | 27 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Nystatin | Nystatin | 26 | 22 |
| Torsemide | Torsemide | 26 | suppressed |
| Mesalamine | Mesalamine | 25 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 25 | suppressed |
| Synthroid | Levothyroxine Sodium | 25 | suppressed |
| Amoxicillin | Amoxicillin | 24 | 19 |
| Colchicine | Colchicine | 24 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Thiothixene | Thiothixene | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 22 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 22 | suppressed |
| Testosterone | Testosterone | 22 | suppressed |
| Celecoxib | Celecoxib | 21 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 21 | suppressed |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | suppressed |
| Ezetimibe | Ezetimibe | 20 | suppressed |
| Latanoprost | Latanoprost | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 18 | 15 |
| Folic Acid | Folic Acid | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Famotidine | Famotidine | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Glipizide Er | Glipizide | 16 | suppressed |
| Lacosamide | Lacosamide | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 15 | suppressed |
| Chlorthalidone | Chlorthalidone | 15 | suppressed |
| Dutasteride | Dutasteride | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Ibuprofen | Ibuprofen | 15 | suppressed |
| Jardiance | Empagliflozin | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Meloxicam | Meloxicam | 15 | suppressed |
| Spironolactone | Spironolactone | 15 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Methotrexate | Methotrexate Sodium | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Linzess | Linaclotide | 12 | suppressed |
| Nifedipine Er | Nifedipine | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Travoprost | Travoprost | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 11 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 11 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
| Restasis | Cyclosporine | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Tranylcypromine Sulfate | Tranylcypromine Sulfate | 11 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Valsartan | Valsartan | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $90.83 · 1 records | EMD Serono, Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error